Harnessing Medicinal Chemical Intuition from Collective Intelligence

07 May 2024, Version 1

Abstract

Over the last decade, the combination of collective intelligence with computational methods has transformed complex problem-solving. Here, we investigate if and how collective intelligence can be applied to drug discovery, focusing on the lead optimization stage of the discovery process. For this study, 92 Sanofi researchers with diverse scientific expertise participated anonymously in a lead optimization exercise. Their feedback was used to build a collective intelligence agent that was compared to an artificial intelligence model developed in parallel. This work has led to three major conclusions. First, a significant improvement of collective versus individual decisions in optimizing ADMET endpoints is observed. Second, for all endpoints apart from hERG inhibition, the collective intelligence performance exceeds the artificial intelligence model. Third, we observe a complementarity between collective intelligence and AI for complex tasks, demonstrating the potential of hybrid predictions. Overall, this research highlights the potential of collective intelligence in drug discovery. The entire dataset, including questionnaire responses, and developed models are available for access on GitHub.

Keywords

medicinal chemistry intuition
collective intelligence
artificial intelligence
lead optimisation
ADMET
drug design

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.